Clinical Trial Update: Pharmacokinetic/Pharmacodynamic Evaluation Amikacin in Critically Ill Patients Admitted at the Emergency Department [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic/pharmacodynamic evaluation of amikacin in critically ill sepsis patients admitted from the emergency department has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Amikacin (amikacin)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Sepsis | Phase 4 | Status: COMPLETED